0.0001
0.0000
(0.00%)
At close: 3:34:37 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
327.0000
319.0000
592.0000
391.0000
98.0000
Cost of Revenue
407.0000
569.0000
796.0000
624.0000
496.0000
Gross Profit
-80.0000
-250.0000
-204.0000
-233.0000
-398.0000
Operating Expense
9,494.0000
11,657.0000
17,647.0000
17,691.0000
18,649.0000
Operating Income
-9,574.0000
-11,907.0000
-17,851.0000
-17,924.0000
-19,047.0000
Net Non Operating Interest Income Expense
-602.0000
-761.0000
-1,252.0000
-717.0000
-464.0000
Other Income Expense
-418.0000
-199.0000
506.0000
-392.0000
254.0000
Pretax Income
-10,594.0000
-12,867.0000
-18,597.0000
-19,033.0000
-19,257.0000
Net Income Common Stockholders
-16,102.0000
-12,867.0000
-18,597.0000
-25,178.0000
-19,257.0000
Diluted NI Available to Com Stockholders
-16,102.0000
-12,867.0000
-18,597.0000
-25,178.0000
-19,257.0000
Basic EPS
-2.96
-15.89
-86.15
-162.00
-180.00
Diluted EPS
-2.96
-15.89
-86.15
-162.00
-180.00
Basic Average Shares
2,883.4200
809.5060
215.8630
156.3170
107.0660
Diluted Average Shares
2,883.4200
809.5060
215.8630
156.3170
107.0660
Total Operating Income as Reported
-9,574.0000
-11,907.0000
-17,851.0000
-17,924.0000
-19,047.0000
Total Expenses
9,901.0000
12,226.0000
18,443.0000
18,315.0000
19,145.0000
Net Income from Continuing & Discontinued Operation
-10,594.0000
-12,867.0000
-18,597.0000
-19,033.0000
-19,257.0000
Normalized Income
-10,293.0000
-12,565.0000
-18,555.0000
-18,779.0000
-19,256.0000
Interest Expense
602.0000
761.0000
1,252.0000
717.0000
464.0000
Net Interest Income
-602.0000
-761.0000
-1,252.0000
-717.0000
-464.0000
EBIT
-9,992.0000
-12,106.0000
-17,345.0000
-18,316.0000
-18,793.0000
EBITDA
-9,355.0000
-11,429.0000
-16,508.0000
-17,615.0000
-18,161.0000
Reconciled Cost of Revenue
407.0000
569.0000
796.0000
624.0000
496.0000
Reconciled Depreciation
637.0000
677.0000
837.0000
701.0000
632.0000
Net Income from Continuing Operation Net Minority Interest
-10,594.0000
-12,867.0000
-18,597.0000
-19,033.0000
-19,257.0000
Total Unusual Items Excluding Goodwill
-301.0000
-302.0000
-42.0000
-254.0000
-1.0000
Total Unusual Items
-301.0000
-302.0000
-42.0000
-254.0000
-1.0000
Normalized EBITDA
-9,054.0000
-11,127.0000
-16,466.0000
-17,361.0000
-18,160.0000
12/31/2020 - 2/14/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PETVW PetVivo Holdings, Inc.
0.0499
+75.09%
VIVE Viveve Medical, Inc.
0.0002
0.00%
PHCCF PHC Holdings Corporation
6.28
0.00%
HYPR Hyperfine, Inc.
0.9623
-1.81%
SGHT Sight Sciences, Inc.
3.1100
-1.27%
BJDX Bluejay Diagnostics, Inc.
3.4700
+3.27%
NPCE NeuroPace, Inc.
12.00
+1.35%
RPID Rapid Micro Biosystems, Inc.
1.2650
+16.06%
NUWE Nuwellis, Inc.
1.0700
+1.90%
SINT Sintx Technologies, Inc.
3.3400
+4.37%